Press Releases
- Annual Report 2014 Active Biotech AB (publ) April 30, 2015 10:00 (CEST)
- Teva and Active Biotech Announce First Patient Enrolled in Phase II Study Evaluating Laquinimod for Primary Progressive MS April 23, 2015 20:32 (CEST)
- Teva and Active Biotech Announce First Patient Enrolled in Phase II Study Evaluating Laquinimod for Primary Progressive MS April 23, 2015 20:00 (CEST)
- Active Biotech AB Interim report January - March 2015 April 23, 2015 08:34 (CEST)
- Active Biotech AB Interim report January - March 2015 April 23, 2015 08:30 (CEST)
- Active Biotech and Ipsen announce their decision to discontinue the development of tasquinimod in prostate cancer April 16, 2015 07:19 (CEST)
- Active Biotech and Ipsen announce their decision to discontinue the development of tasquinimod in prostate cancer April 16, 2015 07:00 (CEST)
- Active Biotech AB Year-end report January - December 2014 February 11, 2015 08:36 (CET)
- Active Biotech AB Year-end report January - December 2014 February 11, 2015 08:30 (CET)
- Number of shares and votes in Active Biotech January 30, 2015 08:39 (CET)